Mon, Sep 21, 2026 - Page 37
8070 indexed SquawkNews stories from this UTC day. Showing 4321-4440.
L
ResMed FY26 revenue and EPS rise; RBC upgrades price target
ResMed reported FY26 revenue of $5.7B, EPS up 16%, and sleep-device sales gains (Americas +8%, international +13%). The company returned about $1B to shareholders and flagged FY27 upside tied to innovation and digital he
EARNINGS | Sep 21, 2026, 11:32 AM UTC
L
Kinross recap: Q2 2026 FCF $725M+, $600M YTD buybacks
Kinross Gold reported Q2 2026 free cash flow of $725M+ and returned roughly $600M year-to-date through about $520M of buybacks (~17.3M shares, ~4% fewer). It also declared a $0.04 quarterly dividend and named Bernard Wes
EARNINGS | Sep 21, 2026, 11:32 AM UTC
L
Enova reaffirms 2026 guidance and starts accelerated buybacks
Enova International reaffirmed its Q3 and full-year 2026 guidance and began accelerated share repurchases. Three analysts cut price targets: Stephens to $205, TD Cowen to $220, and Citizens to $215, with Stephens' $205 i
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
TD Cowen: CLS could see multi-year 400G/800G switch demand
TD Cowen analyst John Shao said Celestica could benefit from a multi-year AI networking hardware refresh, with 400G/800G Ethernet switch upgrades through 2029 extending replacement demand past 2030 and potentially suppor
EQUITY | Sep 21, 2026, 11:32 AM UTC
M
Worthington Enterprises Q1 2027 EPS and revenue outlook eyed
Ahead of fiscal Q1 2027 due Sept. 22, analysts are penciling EPS of $0.76 and revenue of $331.3M. The recap notes sales and EPS slipping from the prior quarter, with attention on integration of Elgin and LSI, margins, ca
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Synchrony Financial raises $500M preferred; CET1 above 13%
Synchrony Financial raised $500M in preferred stock and reported CET1 above 13%, targeting a 16% NIM framework and forecasting NIM improvement in H2. It also cited early Q3 ~8% purchase-volume growth led by super-prime c
RATES | Sep 21, 2026, 11:32 AM UTC
L
Vivmark net rents rise 3.6% YoY; Scotiabank cuts VMRK target
Vivmark Residential reported net effective asking rents up 3.6% year over year, physical occupancy at 95.7%, and renewals covering 60% of residents. Scotiabank reduced its price target on VMRK to $66.00 from $70.00.
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Rani Therapeutics Highlights RT-114 Data and Manufacturing Scale-Up
Rani Therapeutics said it reported strong clinical data for RT-114, highlighted RaniPill oral biologic delivery, and stated it scaled manufacturing while maintaining a solid cash runway to fund programs, partnerships and
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
X-Energy advances Xe-100 SMR through UK GDA process
X-Energy is progressing its Xe-100 SMR through the UK Generic Design Assessment, and has been the subject of a Buy initiation with a $22 target, citing licensing, services, fuel sales and an asset-light recurring-revenue
ENERGY | Sep 21, 2026, 11:32 AM UTC
L
YETI targets Bags & Soft Coolers $1B growth; Stifel lifts PT
YETI is positioning Bags & Soft Coolers as a potential $1B growth platform, prioritizing EMEA and APAC expansion and linking capital allocation and productivity to 2025–2030 targets. Stifel upgraded YETI to Buy and set a
EQUITY | Sep 21, 2026, 11:32 AM UTC
M
Movado Group weekly recap cites Q2 results and younger-buyer push
Movado Group reported Q2 sales of $169.8M and net income of $12.3M, with adjusted EPS of $0.54. The company said it targets younger buyers with smaller-case models, runs a 145th-anniversary campaign featuring Julianne Mo
EQUITY | Sep 21, 2026, 11:32 AM UTC
H
CHINA PLANS TO DROP A 15% TARIFF ON US LNG THIS WEEK, POTENTIALLY REOPENING TRADE BETWEEN THE TWO NATIONS. NEW DEALS COULD FOLLOW. (SM Circulations)
CHINA PLANS TO DROP A 15% TARIFF ON US LNG THIS WEEK, POTENTIALLY REOPENING TRADE BETWEEN THE TWO NATIONS. NEW DEALS COULD FOLLOW. (SM Circulations)
GEOPOLITICS | Sep 21, 2026, 11:32 AM UTC
L
vTv says CATT1 Phase III enrollment nearing completion; options granted
vTv Therapeutics says its Phase III CATT1 trial enrollment is nearing completion, with top-line data expected in 2027 and funding deemed sufficient. The company granted inducement stock options to a non-executive employe
EARNINGS | Sep 21, 2026, 11:32 AM UTC
M
Scholar Rock wins FDA approval, launches ISEMBYLD in U.S.
Scholar Rock (SRRK) says the FDA approved ISEMBYLD for SMA patients on SMN2 therapy and that it has launched U.S. supply. The company plans EU and Japan filings, expects U.S. pricing at about $11,659 per vial (~$310k/yea
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
MGY completes $2.57B acquisition; files 8-Ks on Sept. 14
Magnolia Oil & Gas Corp. completed a Sept 10, 2026 acquisition for $2.57B cash (adjusted), issued 32,203,000 shares, and assumed the target’s 2029 notes. On Sept 14, the company filed 8-Ks disclosing a direct/off-balance
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Janus Living boosts liquidity with $1.25B revolver; declares $0.0475 dividend
Janus Living says it has a $1.25B undrawn unsecured revolver maturing March 2030 priced at SOFR+105 bps, and it announced a $0.0475 monthly Q4 2026 dividend (annualized $0.57) under its regular record/payment schedule.
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
TD targets 100 U.S. branches by 2028; expands AI use
Toronto-Dominion Bank (NYSE:TD) plans U.S. growth targeting 100 branches by 2028 in Florida and the Carolinas, while working through regulatory remediation. The bank’s U.S. unit is ramping AI across operations, including
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Orchid Island Capital reports $10.705B borrowings and whole-pool mix
Orchid Island Capital, Inc. (NYSE: ORC) carried $10.705B in borrowings as of Aug 31, 2026, at a weighted average repo rate of 3.77% and 14-day average maturity. It reported 96.0% of mortgage assets qualified as whole-poo
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Rithm discloses Q3 preferred dividends and Ballston office sale
Rithm Capital Corp. disclosed Q3 2026 preferred dividends tied partly to 3-month SOFR, sold a repositioned 188,014-sqft Ballston office at 4075 Wilson Blvd to Piedmont Realty for $56.25M, and named Ann DeVries as Head of
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
ALM - Almonty’s Sangdong Processing Plant Receives Final Operational Certification -- Phase I is Now Commercially Operational
ALM - Almonty’s Sangdong Processing Plant Receives Final Operational Certification -- Phase I is Now Commercially Operational
NEWS | Sep 21, 2026, 11:32 AM UTC
L
NetSTREIT reports Q2 2026 NOI $52.2M, diluted AFFO $0.35
NetSTREIT Corp. reported Q2 2026 property NOI of $52.2M and diluted AFFO of $0.35 per share. Mizuho maintained an Outperform rating.
EARNINGS | Sep 21, 2026, 11:32 AM UTC
L
BXP declares $0.70 quarterly dividend for July–Sept 2026
BXP Inc announced a $0.70 quarterly cash dividend for July–Sept 2026, payable Oct. 30 to holders of record Sept. 30. The update cites rent growth in San Francisco and Manhattan supporting the REIT’s income outlook.
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
TPG RE Finance Trust prices $1.0B CRE CLO; declares $0.24 dividend
TRTX priced a $1.0B CRE CLO, TRTX 2026-FL8, targeting about $820M of investment, with 30-month reinvestment at Term SOFR+1.43%, and declared a $0.24 Q3 2026 cash dividend payable Oct 23.
RATES | Sep 21, 2026, 11:32 AM UTC
L
Regions RF pilots cloud deposit system and expands AI rollout
Regions Financial says it is piloting a cloud deposit system and using AI tools including GitHub Copilot, alongside document and customer analytics, while planning to add 130—150 new branches and ~75—80 bankers ahead of
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Cabot wins $50M DOE grant; names Erica McLaughlin CEO Oct. 1
Cabot said it won a $50M DOE grant and plans to expand battery conductive additive and battery-grade carbon production by about $75M by end-2028 in Pampa, TX and Franklin, LA. The company also named Erica McLaughlin CEO
EQUITY | Sep 21, 2026, 11:32 AM UTC
M
Oklo shares surge after House Ratepayers Protection Act passes
Oklo (NYSE:OKLO) jumped 11% after the House passed the Ratepayers Protection Act, and the company also secured a multiyear Meta deal to supply power by 2030.
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
Digital Realty partners with AXG for hosted AI across 31 markets
Digital Realty Trust (DLR) says it is partnering with AXG to enable hosted private AI, cloud and edge services across 31 markets, and it cites higher uptime at 99.9999% alongside a focus on growing AI infrastructure cons
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
MSA demos Connected Firefighter platform and UK launches GALLET F1 helmet
MSA Safety showcased its Connected Firefighter Platform (M1 SCBA, MSA HUB live incident data, Repeaters) and unveiled the GALLET F1 helmet in the UK, citing improved protection, updated shields, wider sizing, L360 light,
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
WRLD - World Acceptance Corporation Names John L. Calmes Jr. President and Chief Executive Officer
WRLD - World Acceptance Corporation Names John L. Calmes Jr. President and Chief Executive Officer
NEWS | Sep 21, 2026, 11:32 AM UTC
H
Medicus Pharma Optimizes Portfolio Strategy With High-Value Focus
Medicus Pharma Ltd. (NASDAQ: MDCX ) on Monday announced it will concentrate all future internally sponsored clinical development for its SkinJect asset exclusively on Gorlin syndrome patients presenting with multiple bas
LIVE | Sep 21, 2026, 11:32 AM UTC
M
Crane to acquire Trillium Pumps US for about $240M
Crane Company (NYSE:CR) is set to acquire Trillium Pumps US for about $240M, adding Floway, Wemco, Roto—Jet and WSP, and projecting roughly $115M in incremental revenue by 2026. DA Davidson kept a Buy on Crane and a $245
EQUITY | Sep 21, 2026, 11:32 AM UTC
L
STRR go-shop ends; S-4 planned for 10% Series A preferred
Star Equity Holdings said its go-shop ended after soliciting 93 parties and it found no superior proposal to the Harte Hanks deal. It plans to file an S-4 to register 10% Series A perpetual preferred stock for Harte Hank
MNA | Sep 21, 2026, 11:32 AM UTC
L
Report flags Jackson Financial accounting and affiliate IOU-linked surplus
A report says Jackson Financial used opaque insurance accounting and actuarial assumptions to support aggressive dividends and buybacks, while regulators cautioned that surplus relies on an affiliate IOU. Evercore kept a
EQUITY | Sep 21, 2026, 11:32 AM UTC
M
BKV closes Barnett Shale acquisition; raises $575M convertible notes
BKV closed a Barnett Shale acquisition adding >65 MMcfe/d (50%+ liquids), ~0.35 Tcfe PDP and 117,000 acres plus CCS and a 180 MMcf/d plant, funded with $575M (up to $650M) 1.625% convertible notes due 2031 and capped cal
MNA | Sep 21, 2026, 11:32 AM UTC
L
Genius Sports expands prediction services via Polymarket and Kalshi
Genius Sports says it is supplying crypto betting data, pricing and settlement services to Polymarket and Kalshi, and launching Prediction.com via Legend to aggregate prediction markets with live in-game data and real-ti
CRYPTO | Sep 21, 2026, 11:32 AM UTC
M
Gentherm to issue ~2.9M shares after exchange ratio tweak
Gentherm will issue about 2.9M new shares after an exchange-ratio tweak, trim SpinCo cash to $159M, and pay Modine holders a $1.90/share special dividend at an Oct. 1 close. JP Morgan upgraded THRM from Neutral to Overwe
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
PRTH - Priority Technology Holdings, Inc. Announces Definitive Agreement with Investor Group Led by Chairman and CEO Thomas Priore to Take Company Private
PRTH - Priority Technology Holdings, Inc. Announces Definitive Agreement with Investor Group Led by Chairman and CEO Thomas Priore to Take Company Private
NEWS | Sep 21, 2026, 11:31 AM UTC
L
Jefferies initiates Alpha Teknova coverage with $9 target
Jefferies initiated coverage on Alpha Teknova, Inc. (NASDAQ:TKNO) with a Buy rating and a $9.00 price target, citing the launch of Fill-Tek—a flexible single-use bag filling system spanning 250 mL to 200 L bags and 8 to
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Village Farms cites scalable EU-GMP production and names VP
Village Farms International says it is leveraging scalable EU-GMP-certified production, expanded capacity in Canada and the Netherlands, a solid cash position, and the appointment of Deepak Anand as VP of Government Affa
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
GE Vernova backlog $176B; target ~$200B by early 2027
GE Vernova reported a $176B backlog and management aims for about $200B by early 2027. The stock fell after a sell rating, amid claims of turbine scarcity and rising secondary prices, alongside new wind, hydro, and servi
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Citi upgrades Haemonetics to Buy, raises target to $123
Citi upgraded Haemonetics (NYSE:HAE) to Buy and lifted its target to $123, citing EPS upside if HAE recaptures CSL Plasma revenue and referencing its Jan 9, 2026 acquisition of Vivasure Medical to add vascular closure te
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
MSGE - Madison Square Garden Entertainment Corp. Repurchases $25 Million of MSGE Class A Common Stock
MSGE - Madison Square Garden Entertainment Corp. Repurchases $25 Million of MSGE Class A Common Stock
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Tempus AI wins FDA approval for tumor-only solid tumor assay
Tempus AI said it received FDA approval for a tumor-only solid-tumor assay and set an ADLT price of $4,500 effective Jan. 1, projecting $80—100M in added revenue; shares fell Friday after a post-approval rally tied to re
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Oric update covers rinzimetostat Phase III safety and enozertinib ESMO plans
Oric said rinzimetostat is in Phase III for prostate cancer and that it will continue development. For lung cancer with brain metastases, Oric said enozertinib data will be presented at ESMO as it outlines partner plans
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
JACK - Jack in the Box Inc. Appoints Former Starbucks CFO Rachel Ruggeri to Board of Directors
JACK - Jack in the Box Inc. Appoints Former Starbucks CFO Rachel Ruggeri to Board of Directors
NEWS | Sep 21, 2026, 11:31 AM UTC
L
Veracyte bolsters cash; adds Prosigna and TrueMRD
Veracyte said it received $150M upfront plus up to $30M tied to UroAmp reimbursement, while adding Prosigna and TrueMRD and pursuing Convergent cost synergies. The company also reiterated its 2026 adjusted EBITDA guidanc
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Brinker Q2 same-restaurant sales up; 3–5% annual buybacks
Brinker International reported Q2 same-restaurant sales up 5%, with revenue and profit gains, and said it plans 3–5% annual buybacks while pursuing value pricing and hospitality upgrades to increase Chili’s traffic.
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Treace expands foot and ankle franchise with new devices
Treace Medical Concepts is adding Lapiplasty Lightning and Tailorplasty MIS bunionette devices, plus Treace X-ray cloud, and cites SPRINT SpeedPlate data for rapid weight-bearing and a 96.6% 12-month union rate, with upd
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Brookfield Asset Management details AI fund and monetization plans
Brookfield Asset Management says it raised and largely deployed fresh capital, accelerated monetizations, and expects fee-bearing capital and earnings to grow through 2031. It also secured a $2 billion Nvidia commitment
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
PBI - Pitney Bowes Inc. Announces Results of Its Cash Tender Offers for Two Series of Notes
PBI - Pitney Bowes Inc. Announces Results of Its Cash Tender Offers for Two Series of Notes
NEWS | Sep 21, 2026, 11:31 AM UTC
L
Perpetuals.com closed business combination; FY2026 net loss
Perpetuals.com Ltd (Sponsored ADR, NASDAQ:PDC) closed its business combination on Jan 20, 2026. It reported ¥2.8B FY2026 net loss tied to integration and product costs, while scaling UpsideOnly to 500,000+ users, with ¥1
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Texas Capital Bancshares to shift primary listing to TXSE
Texas Capital Bancshares will move its primary listing from Nasdaq to the Texas Stock Exchange, ending Nasdaq trading Oct. 7, 2026. TXSE trading and ticker changes to TXCP/TXCP PRB are effective Nov. 9, 2026, with Chief
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Crown Castle COO Cathy Piche to depart Sept. 23, 2026
Crown Castle said COO Cathy Piche will leave the role Sept. 23, 2026 and stay on as special advisor through Feb. 22, 2027 while a successor search proceeds. JPMorgan cut its price target for CCI to $80 from $85 on a revi
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
AutoNation earnings preview cites EPS, revenue estimates and revolver boost
Ahead of Oct. 22, 2026 earnings, AutoNation is forecast to earn $5.72 per share on $7.11B revenue, trading near an 8.1x forward P/E. Analysts’ targets are cited at $232–$250. The company reportedly boosts its revolver to
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Rhythm Pharmaceuticals updates obesity pipeline timelines and Phase 3 plan
Rhythm Pharmaceuticals is advancing oral MC4R agonist bivamelagon with a Phase 3 program planned by end-2026 for rare obesity indications. Its RM-718 reported a mean 11.6% BMI drop at 16 weeks in acquired hypothalamic ob
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Vicor Q2 backlog rises on product sales, AI-patent royalties
Vicor reported a Q2 backlog of $380M, up 26% QoQ and 145% YoY, attributing growth to product sales and VPD patent royalties tied to AI accelerators and power management. The company also expanded capacity with new Merrim
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Northern Trust reports custody, AUM and raises prime rate to 7.00%
Northern Trust reported $20.0T in custody/administration and $2.0T AUM, including $534B in Northern Trust Wealth Management, and raised its prime rate to 7.00%. It also named Cynthia Brown president of its Delaware trust
RATES | Sep 21, 2026, 11:31 AM UTC
L
Ecopetrol names acting CEO for Sept 15, 2026
Ecopetrol said Alfonso Camilo Barco Muñoz will become Acting CEO on Sept 15, 2026 as Juan Carlos Hurtado Parra departs. Board member Hildebrando Vélez Galeano also resigns effective the same date.
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Veraxa advances BiTAC dual-targeting platform; hires CFO Raju Willener
Veraxa Biotech AG (NASDAQ:VRXA) is advancing its oncology pipeline with BiTAC, a dual-targeting platform intended to trigger cytotoxicity only when two tumor antigens are engaged to improve tumor selectivity. The company
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Immersion reports Q1 FY2027 results; BNED consolidation added
Immersion (NASDAQ:IMMR) reported Q1 FY2027 revenue of $294.4M and GAAP net income of $4.9M ($0.17/sh). Non-GAAP net income was $16.6M ($0.50/sh). Operating expenses were $80.4M. The quarter includes consolidation of Barn
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Kilroy raises 2027 sector NOI outlook on leasing demand
Kilroy Realty Corp. (KRC) said strong AI/tech and life-sciences leasing in San Francisco, Bellevue and San Diego is lifting demand for its office and life-science assets, forecasting higher sector NOI in 2027 vs 2026, an
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
UPXI reports FY2026 loss driven by unrealized Solana holdings
Upexi reported a $246.1M FY2026 loss, largely driven by $195.1M unrealized Solana holdings. The company says cost cuts plus staking (≈95% of SOL staked) should make staking revenue exceed cash operating expenses this qua
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Weekly Recap: 3-year supply deal with SAS Ammo and Type 23 ATF license
First Breach, Inc. (NASDAQ:FBDT) landed a 3-year supply deal with SAS Ammo for 5.56mm and 9mm rounds with monthly minimums rising from 3M to at least 8M by Oct 2026, and obtained an ATF Type 23 Federal Explosives License
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Jefferies defends $500M fraud claim; Jupiter-linked loans privately placed
Jefferies Financial Group says it is defending against a $500 million international fraud claim and seeking to halt asset dissipation. It also reports privately placing Jupiter-linked loans at about $0.89—$0.91 per dolla
RATES | Sep 21, 2026, 11:31 AM UTC
L
Fennec Pharmaceuticals weekly recap highlights PEDMARK momentum
Fennec Pharmaceuticals reported revenue growth and positive EBITDA from commercial execution. The company attributes sales to PEDMARK, its sole FDA-approved drug to prevent cisplatin hearing loss, and cites IP protection
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Satellogic to launch NewSat satellites with inter-satellite links Oct 2026
Satellogic said it will launch two NewSat Mark VI satellites with inter-satellite links and a NewSat Mark V in Oct 2026 to expand its ISL-enabled fleet and sovereign capacity, sending SATL up over 4% in early trading.
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Boot Barn raises Q2 sales and EPS outlook
Boot Barn Holdings (NYSE:BOOT) raised its Q2 outlook to the high end for sales and EPS. CEO John Hazen said the retailer is using nearby data-center growth and AI-driven demand shifts to optimize local store inventory an
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
TEN Holdings approves $2.0M discretionary buyback through 2026
TEN Holdings, Inc. (NASDAQ: XHLD) approved a discretionary share buyback of up to $2.0M through Dec. 31, 2026 and partnered with GLSoft to accelerate product development and testing for the Ten Events platform.
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Sandisk Q4 results and S&P 100 addition in focus
Sandisk (SNDK) reported Q4 fiscal 2026 revenue of $8.97B and EPS of $43.97, driven by AI memory and high-speed NAND demand, and will join the S&P 100 on Sept. 21.
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Weekly recap: remibrutinib Phase III success, ALS program halt
Recap highlights remibrutinib Phase III success and a positive CHMP opinion for Cosentyx alongside later-stage failures and safety suspensions, plus investor calls for board changes and reported expansion into DLL3 CAR-T
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
PBT declares Oct. 15 distribution; SoftVest and Blackbeard form New PBT
Permian Basin Royalty Trust (PBT) declared a $0.019593 per unit Oct. 15 distribution on 46,608,796 units. The report also says SoftVest and affiliates struck a deal with Blackbeard to form New PBT, and >15% holders sough
ENERGY | Sep 21, 2026, 11:31 AM UTC
L
Virtuix says Omni One orders triple YoY since Meta Quest launch
Virtuix Holdings said Omni One orders are ~3x YoY since the June Meta Quest launch, driven by sales into VA for clinical evaluation. The company also cited progress on larger U.S. defense and enterprise contracts and ong
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Jack Henry posts FY26 revenue up 7.3%; Raymond James reaffirms Strong Buy
Jack Henry & Associates reported FY26 revenue up 7.3%, citing record core wins, strong free cash flow, and AI/platform investments including SMB product Tap2Local. Raymond James reaffirmed a Strong Buy, and Jack Henry re
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Erayak Power expands residential backup roadmap and U.S. DTC push
Erayak Power Solution Group is scaling from portable units to 30 kW residential backups using multi- and tri-fuel inverters (2400PD, 4500PD, 6800PD, 6800PT) and expanding U.S. reach via Amazon, Walmart Marketplace, direc
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Algorhythm appoints CEO and engineering lead; adopts Azure pyrolysis-to-power tech
Algorhythm Holdings (RIME) appointed Andrew Thompson as CEO and board chair, added Kevin Tangen to lead engineering, and said it is adopting Azure’s pyrolysis-to-power technology to deliver dispatchable, carbon-neutral p
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
FDA grants Priority Review for Insmed’s ARIKAYCE sNDA; PDUFA Jan. 28, 2027
Insmed said the FDA granted Priority Review for its ARIKAYCE sNDA for MAC lung disease, with a PDUFA date of Jan. 28, 2027. Roth Capital cut its price target on INSM from $212 to $198.
REGULATION | Sep 21, 2026, 11:31 AM UTC
M
Mirum stock gains on Q2 revenue, upgraded outlook
Mirum Pharmaceuticals rallied after strong Q2 revenue tied to LIVMARLI and its bile acid portfolio, expansion into new rare-disease patients, and an upgraded full-year outlook. Investors are awaiting the Sept. 26 FDA dec
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Rimini Street expands ANZ Level 4 support with Datacom
Rimini Street partnered with Datacom to provide Level 4 support for Oracle and SAP in Australia and New Zealand, and reappointed Steven Hershkowitz as Executive VP and Chief Revenue Officer effective Sept. 14, 2026.
MNA | Sep 21, 2026, 11:31 AM UTC
L
EyePoint reports DURAVYU/LUGANO topline wet AMD data and sets DME
EyePoint reported August 2026 topline DURAVYU/LUGANO wet AMD data and set LUCIA and DME toplines for Q4 2026 and Q4 2027. The company granted a non-statutory option for up to 3,000 shares at $3.66 with a ten-year term an
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Precision BioSciences recap highlights ARCUS cccDNA elimination and 2028 cash runway
Precision BioSciences said its ARCUS platform supports PBGENE—HBV and PBGENE—DMD, citing durable cccDNA elimination and improved safety seen in HBGENE data, a cash runway into 2028, regulatory designations, and progress
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Tenable reports record Q2 revenue; raises $800M convertible notes
Tenable says it delivered record Q2 revenue and customer growth supported by Tenable One expansion and a Hexa launch. The company also raised $800M via 0.25% convertible notes to refinance debt, fund buybacks and support
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Associated Bank raises prime rate to 7.00%
Associated Bank raised its prime rate to 7.00% from 6.75%, effective Sept. 17, 2026, resetting pricing for variable-rate loans and customer borrowings. Associated Banc-Corp kept its FY2026 guidance unchanged.
RATES | Sep 21, 2026, 11:31 AM UTC
L
ICU Medical recalls sodium chloride after labeling mix-up
ICU Medical said a customer found a potassium chloride bag in the overwrap of a 0.9% sodium chloride 100 mL single-pack, prompting a recall of one lot. The company also disclosed plans for a major joint venture to expand
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
JLL: Cross-border commercial property investment rises to $71.8B H1
JLL says global cross-border commercial property investment jumped 56% YoY to $71.8B in H1. It also reports Highly Transparent markets saw volumes surge 64% over two years, led by Asia and Europe and an office rebound.
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Boxabl begins trading after SPAC merger; investors assess debut
Boxabl, Inc. (Nasdaq: BXBL) began trading July 20, 2026 after a SPAC merger. The market will parse the debut price, public float, use of proceeds and management guidance as the company scales automated, AI-driven mass pr
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Hyperliquid Strategies enters Nov. 12 earnings with HYPE token disclosure
For Nov. 12 earnings, analysts estimate EPS at $0.12 with ~$9.78M revenue. The company discloses ~33.2M HYPE tokens (~$2.5B) and reports ~$1.4B left on a $2.5B Chardan equity line.
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Guardant Health says Shield reaches 80% of eligible adults
Guardant Health said Shield now reaches 80% of eligible adults, with Evernorth’s EviCore to cover the colorectal cancer Shield blood test for average-risk patients aged 45+ starting Jan. 1, 2027 across 23 states.
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Rocket Pharmaceuticals details advancing cardiovascular programs and RP-A501 pediatric update
Rocket Pharmaceuticals says three cardiovascular gene-therapy programs are advancing and that Phase 2 RP-A501 interim data show good tolerability with early pediatric efficacy signals; the company says cash runway extend
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Datavault AI reiterates $200M 2026 revenue target
Datavault AI said management will stick to a $200M 2026 revenue target while consolidating IDE, NILvault and APEX onto one infrastructure to authenticate, tokenize and trade assets, linking QEST tokens to Project Qestrel
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Lisata Therapeutics funds MAR programs with $1,491.37 Series C
Lisata Therapeutics raised new financing via Series C non-voting convertible preferred shares to fund MAR001/005 and MAR002 programs, including planned Phase 2b in severe hypertriglyceridemia and Phase 2 in acromegaly, w
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Weekly Recap: Raised 2026 revenue guide and GATE revenue, EBITDA
Ondas Inc. (NASDAQ:ONDS) reported Q2 revenue of $83.8M, raised its 2026 guide to $525—$550M while deploying ~$325M on DZYNE and Cyberhawk and holding ~$1.4B cash; it forecasts strong GATE growth but faces heavy short int
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
IBIO-600 Phase 1 enrollment completed; $88M cash runway reported
iBio says enrollment is complete in its Phase 1 single-ascending-dose trial of IBIO-600 and expects interim human data soon. An updated presentation shows $88.0M cash runway. HC Wainwright initiated coverage with a Buy r
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Alkermes reports positive Phase 1b topline for ALKS 7290
Alkermes (NASDAQ:ALKS) said its oral OX2R agonist ALKS 7290 showed dose-dependent clinical improvements and favorable safety in adults with ADHD, with Phase 2 now enrolling. The company also added Anne C. Whitaker to its
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
HYPR gets Nasdaq delisting warning; Swoop MRI enrollment completed
Hyperfine said Nasdaq issued a delisting warning after HYPR fell below $1 and the company has until March 16, 2027 to comply. Separately, Hyperfine completed enrollment in a multi-center study of its portable Swoop MRI t
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Health Catalyst grants RSUs to incoming CEO, insider buys shares
Incoming CEO Simeon Kohl received 2,747,385 RSUs (initial vesting Sept 14, 2027) and bought 59,000 shares at about $1.7872 each. Health Catalyst also added Tami Reller to the board as chair of Audit and as a member of Co
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Amneal launches FDA-approved 120 mg generic lanreotide
Amneal Pharmaceuticals says it received FDA approval for a 120 mg generic lanreotide (Somatuline Depot) and has launched the injectable with in-house manufacturing and a CGT designation.
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Coda Octopus reports revenue up 9.2% QoQ; DAVD approvals
Coda Octopus Group says Q3 revenue rose 9.2% QoQ, citing a 131% jump in marine rental revenue and a 68.3% increase in Defense Services. The company also cites DAVD Untethered approvals and deliveries, solid margins and c
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Nebius posts blockbuster quarter; GPU compute price hikes cited
Nebius Group reported Q revenue of $582M (+454% YoY) and $981M for six months, turning adjusted EBITDA to $236M from a year-ago loss. Article links Oct. 1 price hikes on Nvidia GPUs and AMD EPYC Genoa compute to premarke
EARNINGS | Sep 21, 2026, 11:31 AM UTC
L
Hain Celestial seeks $305–310M from international asset sale
Hain Celestial Group says it is racing to complete an international asset sale expected to raise $305–310M to repay term loans, reduce revolver exposure, and reach about $250M pro forma debt by June 30, 2026.
MNA | Sep 21, 2026, 11:31 AM UTC
H
Identiv sells IoT business to Trackonomy; appoints interim CEO
Identiv sold its IoT business and brand to Trackonomy for $50M in preferred equity, rebranded as INVE Technologies and pivoted to physical AI SaaS. CEO Kirsten Newquist will resign Sept 21, 2026, with James Greenwell nam
MNA | Sep 21, 2026, 11:31 AM UTC
M
Aethlon Medical to merge with North Immunology; Nasdaq listing planned
Aethlon Medical will merge with North Immunology, seeking a Nasdaq listing under ticker NRTX backed by an oversubscribed $180M PIPE to fund operations into H2 2028, with NOR—101 targeted toward a Phase 1a trial in 2027;
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
FRT: compressed cap rates outlook and Scotiabank trims PT
Federal Realty Investment Trust said compressed cap rates will slow NOI growth through 2027 as it emphasizes disciplined capital recycling and tenant-focused value creation. Scotiabank trimmed its price target on FRT to
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Angi plans Nov. 17 Investor Day with AI roadmap
Angi Inc (NASDAQ:ANGI) will host an Investor Day Nov 17 in New York, unveiling an AI-first product roadmap, live demo and financial framework, and an Angi-branded ChatGPT agent tied to OpenAI’s Sponsored Agent pilot for
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
FG Nexus repurchases $48M and plans Nasdaq ticker change
FG Nexus said it repurchased about 4.0M common shares (~$48M, ~46% of pre-program) and ~275K preferred shares (~$6.9M, ~31% of pre-program) while buyback programs remain active, and it will rebrand to FG Communities Hold
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Incyte weekly recap highlights MPNs Phase III/POC data
Incyte reported positive proof-of-concept and Phase III data across MPNs, solid tumors and dermatology, closed the Vega Therapeutics deal adding latarcibart, and outlined plans to grow post-2029 while expecting JAKAFI XR
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Halozyme prices $1.3B 1.50% convertible notes with $200M option
Halozyme Therapeutics (NASDAQ:HALO) priced $1.3B of 1.50% convertible notes, with an option adding about $200M, raising about $1.275B to fund growth after a record Q2.
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Core Scientific deal with AMD supports 530 MW supply
Core Scientific Inc (NASDAQ:CORZ) agreed to supply 530 MW across five sites for AMD, with options to expand to 2.5 GW. Wells Fargo initiated Overweight coverage and set a $28 target citing execution and leasing upside.
MNA | Sep 21, 2026, 11:31 AM UTC
L
On Holding projects CHF 3.55B sales by 2026
On Holding says it targets at least CHF 3.55B sales by 2026 and outlines a three-year plan at an investor day, citing a tougher retail backdrop and mixed analyst views. It also plans to enter football in 2027 with Kylian
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Delixy to do 1-for-5 reverse split Sept. 28, 2026
Delixy Holdings Limited Class A (DLXY) will implement a 1-for-5 reverse split on Sept 28, 2026 (new CUSIP G2703G111), reducing Class A to ~1,434,800 shares. Separately, it signed a non-binding LOI to acquire or merge for
EQUITY | Sep 21, 2026, 11:31 AM UTC
H
FDA authorizes IQOS; Philip Morris raises dividend 8.8%
Philip Morris International said the FDA granted marketing authorization for its IQOS devices and consumables, and it increased its quarterly dividend 8.8% to $1.60. The company also stated smoke‑free product sales reach
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
F5 says Q3 AI security purchases doubled as BIG—IP integrates
F5 said Q3 FY2026 customers doubled purchases of its AI security solutions quarter over quarter, citing its partnership with Omnissa to integrate BIG—IP Zero Trust Access, LTM and DNS into Omnissa Horizon/Access for DMZ
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Health Canada approves Pfizer XFG vaccine for Canadian distribution
BioNTech’s Sponsored ADR (NASDAQ:BNTX) rose after Health Canada approved Pfizer’s XFG—adapted COVID vaccine for imminent Canadian distribution, according to TradingView News.
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Boxlight regains Nasdaq compliance; raises $6.6M in Series D PIPE
Boxlight Corporation (NASDAQ:BOXL) regained Nasdaq compliance after a Sept 2, 2026 panel decision and raised about $6.6M in a Series D PIPE, including a $15M equity line and a $2.9M debt-to-equity swap. The company also
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Astera Labs expands Leo family sampling with Leo X—Series launch
Astera Labs says it is ramping design activity and has launched Leo X—Series for fabric, with attached memory, and updated Leo 2 E—Series/P—Series for CPU with attached expansion; demos are planned at the AI Infra Summit
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Bioceres narrows 4Q26 loss; Pro Farm foreclosure auction shifts units
Bioceres said Pro Farm Group’s January 2026 foreclosure auction moved the unit to discontinued operations amid disputed note acceleration and ongoing legal fights. BIOX also narrowed its 4Q26 net loss to $31.8M and poste
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Cid Holdco under Nasdaq review; completes $1.09M debt conversion
Cid Holdco Inc is under review by a Nasdaq hearings panel for falling below minimum market value and filing its Form 10-Q late. The company also completed a restructuring that converted about $1.09M of debt into equity a
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Stardust Power raises ATM cap to $8.99M after sub-$1 bid
Stardust Power increased its at-the-market (ATM) offering cap to $8.99M while Nasdaq flagged a sub-$1 bid price; company compliance is due by March 10, 2027. The update also mentions funding progress toward a two-phase M
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
Apogee sets Oct. 6 call for Q2 2027 results
Apogee Enterprises will report fiscal Q2 2027 results Tuesday, Oct. 6 before the open and hold an 8:00 a.m. CT conference call with webcast. The company also added Julie K. Streich as an independent director and Audit Co
EQUITY | Sep 21, 2026, 11:31 AM UTC
M
PBF prices $500M exchangeable notes due 2032
PBF Energy priced $500M exchangeable notes due 2032, exchangeable at about 10.3306 shares per $1,000 (about $96.80/share). Proceeds are expected to fund repayment of 2030 notes and hedges, with capped-call transactions a
EQUITY | Sep 21, 2026, 11:31 AM UTC
L
Atossa Therapeutics advances Z-Endoxifen with orphan designations
Atossa Therapeutics says its (Z)-Endoxifen program received Rare Pediatric Disease and Orphan Drug designations for MAS and DMD, completed EVANGELINE Phase 2 enrollment after dosing ~800 patients, and expects IND clearan
EQUITY | Sep 21, 2026, 11:31 AM UTC